Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | TP53 | P04637 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | TGFBR1 | P36897 | 4/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24731790 | 0.87 | NPC1 (0.41) | KDM4ENPC1MAPTTP53SMN1; SMN2 | |
| SCHEMBL24731956 | 0.80 | RAB9A (0.49) | KDM4ENPC1MAPTRAB9AALDH1A1 | |
| SCHEMBL19161960 | 0.80 | MAOA (0.40) | KDM4ENPC1MAPTSMN1; SMN2RAB9A | |
| SCHEMBL18132503 | 0.78 | KDM4E (0.48) | KDM4ENPC1MAPTTP53SMN1; SMN2 | |
| SCHEMBL19162668 | 0.77 | MAOA (0.38) | KDM4EMAPTALDH1A1HPGDCYP1A2 | |
| SCHEMBL19162667 | 0.76 | MAPT (0.40) | KDM4ENPC1MAPTSMN1; SMN2RAB9A | |
| SCHEMBL25878131 | 0.75 | ALDH1A1 (0.37) | KDM4EMAPTTP53SMN1; SMN2ALDH1A1 | |
| SCHEMBL22097079 | 0.74 | L3MBTL1 (0.42) | NPC1MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL25878190 | 0.74 | L3MBTL1 (0.46) | NPC1MAPTRAB9AALDH1A1HPGD | |
| SCHEMBL23473872 | 0.74 | MAOA (0.39) | KDM4EMAPTALDH1A1HPGDCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230134350-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2023-05-04 | — | — | US | disclosed |
| US-20230134350-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2023-05-04 | — | — | US | disclosed |
| US-11524967-B2 | Heteroacene and organic electroluminescence device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2022-12-13 | — | — | US | disclosed |
| US-20220255013-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2022-08-11 | — | — | US | disclosed |
| US-20210040112-A1 | HETEROACENE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2021-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220255013-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | SLCO4C1, SLCO2A1, SLCO2B1 | KDM4E 2765/4885NPC1 603/4885MAPT 1041/4885 |
| US-20230134350-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | OR10J3, ODC1, OTC | KDM4E 2552/4885NPC1 1403/4885MAPT 1823/4885 |
| US-11524967-B2 | Heteroacene and organic electroluminescence device using the same | POF1B, HCN1, HCN2 | KDM4E 3655/4885NPC1 2350/4885MAPT 1933/4885 |
| US-20210040112-A1 | HETEROACENE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | HCN1, HCN2, CACNA1F | KDM4E 3762/4885NPC1 1912/4885MAPT 1641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.